Selvita researchers publish new paper on CDK8 inhibitor SEL120 in Oncotarget

Krakow, Poland – April 07, 2017 – Selvita, a clinical stage drug discovery and development company focused on innovative medicines for oncology patients, and Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, leading Polish research and development institute focused on oncology, have jointly published most recent results of SEL120…


Selvita presents at BioTrinity 2017

Kraków, Poland – 04 May 2017 – Selvita will participate, as well as present, at the upcoming BioTrinity 2017 conference, taking place in London, UK, on May 08 – 10, 2017. BioTrinity is one of Europe’s leading biopartnering and investment conferences, and the largest of its type in the UK….


Selvita and Sandoz researchers publish paper on Tapentadol synthesis

Kraków, Poland – 08 March 2017 – Selvita and Sandoz researchers have recently jointly published a review on the “Evolution of synthetic routes towards homochiral Tapentadol“, which appeared in the Tetrahedron: Asymmetry, report number XX, on March 7.  The review encompasses analysis of the literature showing that the development of synthetic…